Search

everythinglearnresearchcommunity

for

Search:↓

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

New topical treatment using spherical nucleic acids shows promise in reducing psoriasis inflammation.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

Bullous lupus can cause severe esophageal issues but responds well to corticosteroids and azathioprine.

HPLC may detect prediabetes and diabetes earlier than Immunoturbidimetry because it shows higher A1c levels.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

PDRN, derived from salmon sperm, shows promise in healing wounds, reducing inflammation, and regenerating tissues, but more research is needed to understand its mechanisms and improve its use.

The document concludes that treatments for cicatricial alopecia are not well-supported by evidence, but hair transplantation shows more predictable and satisfactory results.

PRP shows promise for treating hair loss but needs standardized methods to confirm its effectiveness.

Bexarotene gel shows promise as a new treatment for alopecia areata.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

PRP shows promise for treating mild alopecia areata but needs more research for cicatricial alopecias.

PRP shows promise for scarring alopecia but needs more research before replacing current treatments.

Auranofin shows promise as a cancer treatment, especially when combined with other therapies.

Rosemary shows promise in treating alopecia, similar to minoxidil, but more research is needed.

PRP shows promise but lacks consistent evidence and regulation.

PRP shows promise in treating joint and spine issues, but translating lab results to humans is challenging.

Ritlecitinib shows promise for treating alopecia areata, especially with early and extended treatment.

Abrocitinib shows promise for treating various skin conditions beyond atopic dermatitis.

Minoxidil shows promise for alopecia areata, but more research is needed before it can be recommended as a primary treatment.

Curcumin shows promise in reducing pain and inflammation, but more research is needed.

Hederagenin shows promise for cancer and inflammation treatment but needs modifications to improve effectiveness.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

PRP therapy shows promise for anti-aging but lacks consistent evidence and standardization.

PRP generally shows better results for hair regrowth than mesotherapy, but more research is needed.

Platelet-rich plasma shows promise in reducing pain for bladder pain syndrome.

Photothermal conditioning of PRP shows promise for improving hair growth but needs more research for confirmation.

Combining traditional Chinese medicine with microneedles shows promise for effectively treating skin diseases with fewer side effects.

Kindler Syndrome shows diverse symptoms and needs better diagnostic tools and care in resource-limited areas.